Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Patient HLA Germline Variation and Transplant Survivorship.

Petersdorf EW, Stevenson P, Malkki M, Strong RK, Spellman SR, Haagenson MD, Horowitz MM, Gooley T, Wang T.

J Clin Oncol. 2018 Aug 20;36(24):2524-2531. doi: 10.1200/JCO.2017.77.6534. Epub 2018 Jun 14.

2.

KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

Boudreau JE, Giglio F, Gooley TA, Stevenson PA, Le Luduec JB, Shaffer BC, Rajalingam R, Hou L, Hurley CK, Noreen H, Reed EF, Yu N, Vierra-Green C, Haagenson M, Malkki M, Petersdorf EW, Spellman S, Hsu KC.

J Clin Oncol. 2017 Jul 10;35(20):2268-2278. doi: 10.1200/JCO.2016.70.7059. Epub 2017 May 18.

3.

High HLA-DP Expression and Graft-versus-Host Disease.

Petersdorf EW, Malkki M, O'hUigin C, Carrington M, Gooley T, Haagenson MD, Horowitz MM, Spellman SR, Wang T, Stevenson P.

N Engl J Med. 2015 Aug 13;373(7):599-609. doi: 10.1056/NEJMoa1500140.

4.

A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.

Hardikar S, Johnson LG, Malkki M, Petersdorf EW, Galloway DA, Schwartz SM, Madeleine MM.

Gynecol Oncol. 2015 Oct;139(1):90-6. doi: 10.1016/j.ygyno.2015.07.110. Epub 2015 Aug 1.

5.

Donor activating KIR2DS1 in leukemia.

Venstrom JM, Dupont B, Hsu KC, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E.

N Engl J Med. 2014 Nov 20;371(21):2042. doi: 10.1056/NEJMc1411443. No abstract available.

PMID:
25409391
6.

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

Petersdorf EW, Gooley TA, Malkki M, Bacigalupo AP, Cesbron A, Du Toit E, Ehninger G, Egeland T, Fischer GF, Gervais T, Haagenson MD, Horowitz MM, Hsu K, Jindra P, Madrigal A, Oudshoorn M, Ringdén O, Schroeder ML, Spellman SR, Tiercy JM, Velardi A, Witt CS, O'Huigin C, Apps R, Carrington M; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Blood. 2014 Dec 18;124(26):3996-4003. doi: 10.1182/blood-2014-09-599969. Epub 2014 Oct 16.

7.

Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women.

Bodelon C, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM.

Int J Mol Epidemiol Genet. 2013 Nov 28;4(4):218-27. eCollection 2013.

8.

Comparison of statistics in association tests of genetic markers for survival outcomes.

Mendolia F, Klein JP, Petersdorf EW, Malkki M, Wang T.

Stat Med. 2014 Feb 28;33(5):828-44. doi: 10.1002/sim.5982. Epub 2013 Sep 18.

9.

Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study.

Bodelon C, Madeleine MM, Johnson LG, Du Q, Galloway DA, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2014 Jan 15;134(2):437-44. doi: 10.1002/ijc.28364. Epub 2013 Aug 5.

10.

Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.

Morishima Y, Kawase T, Malkki M, Morishima S, Spellman S, Kashiwase K, Kato S, Cesbron A, Tiercy JM, Senitzer D, Velardi A, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1197-203. doi: 10.1016/j.bbmt.2013.05.020. Epub 2013 Jun 6.

11.

Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study.

Resler AJ, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM.

BMC Cancer. 2013 May 1;13:219. doi: 10.1186/1471-2407-13-219.

12.

Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.

Petersdorf EW, Malkki M, Horowitz MM, Spellman SR, Haagenson MD, Wang T.

Blood. 2013 Mar 7;121(10):1896-905. doi: 10.1182/blood-2012-11-465161. Epub 2013 Jan 10.

13.

Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2013 Jul;133(1):201-13. doi: 10.1002/ijc.28000. Epub 2013 Feb 12.

14.

16th IHIW: international histocompatibility working group in hematopoietic cell transplantation.

Petersdorf EW, Malkki M, Hsu K, Bardy P, Cesbron A, Dickinson A, Dubois V, Fleischhauer K, Kawase T, Madrigal A, Morishima Y, Shaw B, Spellman S, Spierings E, Stern M, Tiercy JM, Velardi A, Gooley T; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Int J Immunogenet. 2013 Feb;40(1):2-10. doi: 10.1111/iji.12022. Epub 2012 Dec 28.

15.

Identification of the MICA*070 allele by sequencing and phasing.

Moran D, Morishima S, Malkki M, Petersdorf EW.

Hum Immunol. 2013 May;74(5):557-61. doi: 10.1016/j.humimm.2012.11.009. Epub 2012 Nov 29.

16.

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B, Hsu KC.

N Engl J Med. 2012 Aug 30;367(9):805-16. doi: 10.1056/NEJMoa1200503.

17.

MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation.

Petersdorf EW, Malkki M, Gooley TA, Spellman SR, Haagenson MD, Horowitz MM, Wang T.

Sci Transl Med. 2012 Jul 25;4(144):144ra101. doi: 10.1126/scitranslmed.3003974.

18.

Genotyping of single nucleotide polymorphisms by 5' nuclease allelic discrimination.

Malkki M, Petersdorf EW.

Methods Mol Biol. 2012;882:173-82. doi: 10.1007/978-1-61779-842-9_10.

19.

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon JD, Dubois V, Horowitz MM, Madrigal JA, Morishima Y, Oudshoorn M, Ringden O, Spellman S, Velardi A, Zino E, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Lancet Oncol. 2012 Apr;13(4):366-74. doi: 10.1016/S1470-2045(12)70004-9. Epub 2012 Feb 15. Erratum in: Lancet Oncol. 2012 Apr;13(4):e134-5.

20.

Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.

Bodelon C, Madeleine MM, Johnson LG, Du Q, Malkki M, Petersdorf EW, Schwartz SM.

Gynecol Oncol. 2012 Mar;124(3):525-8. doi: 10.1016/j.ygyno.2011.11.017. Epub 2011 Nov 28.

21.

Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.

Madeleine MM, Johnson LG, Malkki M, Resler AJ, Petersdorf EW, McKnight B, Malone KE.

Breast Cancer Res Treat. 2011 Oct;129(3):887-99. doi: 10.1007/s10549-011-1520-4. Epub 2011 Apr 27.

22.

HLA mismatches and hematopoietic cell transplantation: structural simulations assess the impact of changes in peptide binding specificity on transplant outcome.

Yanover C, Petersdorf EW, Malkki M, Gooley T, Spellman S, Velardi A, Bardy P, Madrigal A, Bignon JD, Bradley P.

Immunome Res. 2011;7(2):4.

23.

Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.

Johnson LG, Schwartz SM, Malkki M, Du Q, Petersdorf EW, Galloway DA, Madeleine MM.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):199-207. doi: 10.1158/1055-9965.EPI-10-0779. Epub 2010 Nov 11.

24.

HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category.

Woolfrey A, Lee SJ, Gooley TA, Malkki M, Martin PJ, Pagel JM, Hansen JA, Petersdorf E.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1382-7. doi: 10.1016/j.bbmt.2010.03.024. Epub 2010 May 4.

25.

Re: An approach to predicting HSCT outcome using HLA-mismatch information mapped on protein structure data.

Hurley CK, Oudshoorn M, Setterholm M, Spellman SR, Petersdorf E, Lee SJ, Gooley T, Malkki M, Horowitz MM.

Biol Blood Marrow Transplant. 2010 Jun;16(6):865-6. doi: 10.1016/j.bbmt.2010.02.012. Epub 2010 Feb 19. No abstract available.

26.

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.

Venstrom JM, Gooley TA, Spellman S, Pring J, Malkki M, Dupont B, Petersdorf E, Hsu KC.

Blood. 2010 Apr 15;115(15):3162-5. doi: 10.1182/blood-2009-08-236943. Epub 2010 Feb 1.

27.

Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.

Maley SN, Schwartz SM, Johnson LG, Malkki M, Du Q, Daling JR, Li SS, Zhao LP, Petersdorf EW, Madeleine MM.

Int J Immunogenet. 2009 Dec;36(6):367-75. doi: 10.1111/j.1744-313X.2009.00877.x. Epub 2009 Sep 24.

28.

What is the role for donor natural killer cells after nonmyeloablative conditioning?

Baron F, Petersdorf EW, Gooley T, Sandmaier BM, Malkki M, Chauncey TR, Maloney DG, Storb R.

Biol Blood Marrow Transplant. 2009 May;15(5):580-8. doi: 10.1016/j.bbmt.2009.01.018.

29.

IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.

Tseng LH, Storer B, Petersdorf E, Lin MT, Chien JW, Grogan BM, Malkki M, Chen PJ, Zhao LP, Martin PJ, Hansen JA.

Transplantation. 2009 Mar 15;87(5):704-10. doi: 10.1097/TP.0b013e318195c474.

30.

Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Malkki M, Wilkerson HW, Farin FM, Carter JJ, Galloway DA, Daling JR, Petersdorf EW, Schwartz SM.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1790-9. doi: 10.1158/1055-9965.EPI-07-2753.

31.

The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.

Shaw BE, Gooley TA, Malkki M, Madrigal JA, Begovich AB, Horowitz MM, Gratwohl A, Ringdén O, Marsh SG, Petersdorf EW.

Blood. 2007 Dec 15;110(13):4560-6. Epub 2007 Aug 28.

PMID:
17726164
32.

Mapping MHC-resident transplantation determinants.

Malkki M, Gooley TA, Horowitz MM, Absi L, Christiansen FT, Cornelissen JJ, Dormoy A, Dubois V, Gagne K, Gluckman E, Haagenson MD, Oudshoorn M, Spellman S, Petersdorf EW; International Histocompatibility Working Group in Transplantation.

Biol Blood Marrow Transplant. 2007 Aug;13(8):986-95.

33.

Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations.

Spierings E, Hendriks M, Absi L, Canossi A, Chhaya S, Crowley J, Dolstra H, Eliaou JF, Ellis T, Enczmann J, Fasano ME, Gervais T, Gorodezky C, Kircher B, Laurin D, Leffell MS, Loiseau P, Malkki M, Markiewicz M, Martinetti M, Maruya E, Mehra N, Oguz F, Oudshoorn M, Pereira N, Rani R, Sergeant R, Thomson J, Tran TH, Turpeinen H, Yang KL, Zunec R, Carrington M, de Knijff P, Goulmy E.

PLoS Genet. 2007 Jun;3(6):e103.

34.

Immune response gene polymorphisms in unrelated donor hematopoietic cell transplantation.

Malkki M, Gooley T, Dubois V, Horowitz M, Petersdorf EW.

Tissue Antigens. 2007 Apr;69 Suppl 1:50-3.

PMID:
17445163
35.

MHC class I, II, and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation.

Malkki M, Gooley T, Horowitz M, Petersdorf EW; IHWG HCT Component.

Tissue Antigens. 2007 Apr;69 Suppl 1:46-9.

PMID:
17445162
36.

Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.

Hsu KC, Pinto-Agnello C, Gooley T, Malkki M, Dupont B, Petersdorf EW.

Tissue Antigens. 2007 Apr;69 Suppl 1:42-5.

PMID:
17445161
37.

Clinical importance of HLA-DPB1 in haematopoietic cell transplantation.

Shaw BE, Gooley T, Madrigal JA, Malkki M, Marsh SG, Petersdorf EW.

Tissue Antigens. 2007 Apr;69 Suppl 1:36-41.

PMID:
17445160
38.

Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors.

Morishima Y, Kawase T, Malkki M, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation Component.

Tissue Antigens. 2007 Apr;69 Suppl 1:31-5.

PMID:
17445159
39.

Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors.

Petersdorf EW, Gooley T, Malkki M, Horowitz M; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Tissue Antigens. 2007 Apr;69 Suppl 1:25-30.

PMID:
17445158
40.

MHC haplotype matching for unrelated hematopoietic cell transplantation.

Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z.

PLoS Med. 2007 Jan;4(1):e8.

41.

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E; International Histocompatibility Working Group.

Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36.

42.

Long-range multilocus haplotype phasing of the MHC.

Guo Z, Hood L, Malkki M, Petersdorf EW.

Proc Natl Acad Sci U S A. 2006 May 2;103(18):6964-9. Epub 2006 Apr 21. Erratum in: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9374.

43.

Genetics of risk factors for graft-versus-host disease.

Petersdorf EW, Malkki M.

Semin Hematol. 2006 Jan;43(1):11-23. Review.

PMID:
16412785
45.

Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation.

Petersdorf EW, Malkki M.

Semin Hematol. 2005 Apr;42(2):76-84. Review.

PMID:
15846573
46.

Limits of HLA mismatching in unrelated hematopoietic cell transplantation.

Petersdorf EW, Anasetti C, Martin PJ, Gooley T, Radich J, Malkki M, Woolfrey A, Smith A, Mickelson E, Hansen JA.

Blood. 2004 Nov 1;104(9):2976-80. Epub 2004 Jul 13.

PMID:
15251989
47.

Analysis of the human hexokinase II promoter in vivo: lack of insulin response within 4.0 kb.

Pirinen E, Heikkinen S, Malkki M, Deeb SS, Jänne J, Laakso M.

Biochim Biophys Acta. 2004 Jan 20;1676(2):149-54.

PMID:
14746909
48.

Identification of a novel HLA-B*07 allele--HLA-B*0726.

Herbut B, Woodman R, Kowalick L, Malkki M, Petersdorf EW, McKenna R.

Tissue Antigens. 2002 Jan;59(1):60-2.

PMID:
11972884
49.

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.

Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A, Malkki M, Gooley T, Storer B, Mickelson E, Smith A, Anasetti C.

N Engl J Med. 2001 Dec 20;345(25):1794-800.

50.

Genomics of unrelated-donor hematopoietic cell transplantation.

Petersdorf E, Anasetti C, Martin PJ, Woolfrey A, Smith A, Mickelson E, Malkki M, Lin MT, Hansen JA.

Curr Opin Immunol. 2001 Oct;13(5):582-9. Review.

PMID:
11544008

Supplemental Content

Loading ...
Support Center